B. Riley Wealth Advisors Inc. Grows Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

B. Riley Wealth Advisors Inc. lifted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 49.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 75,142 shares of the pharmacy operator’s stock after buying an additional 25,013 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $2,360,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Sage Private Wealth Group LLC purchased a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $25,000. EverSource Wealth Advisors LLC grew its stake in Walgreens Boots Alliance by 289.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 915 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 680 shares in the last quarter. Bank of New Hampshire grew its stake in Walgreens Boots Alliance by 56.4% during the 3rd quarter. Bank of New Hampshire now owns 960 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 346 shares in the last quarter. Blume Capital Management Inc. grew its stake in Walgreens Boots Alliance by 35.7% during the 3rd quarter. Blume Capital Management Inc. now owns 950 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 250 shares in the last quarter. Finally, Ten Capital Wealth Advisors LLC grew its position in shares of Walgreens Boots Alliance by 431.1% in the 3rd quarter. Ten Capital Wealth Advisors LLC now owns 1,179 shares of the pharmacy operator’s stock worth $37,000 after acquiring an additional 957 shares in the last quarter. 56.71% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Down 1.5 %

Shares of Walgreens Boots Alliance stock opened at $32.91 on Friday. The business’s fifty day moving average price is $35.86 and its two-hundred day moving average price is $36.45. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.70 and a quick ratio of 0.36. The company has a market capitalization of $28.38 billion, a P/E ratio of -9.57, a PEG ratio of 1.48 and a beta of 0.72. Walgreens Boots Alliance, Inc. has a 1-year low of $30.39 and a 1-year high of $48.62.

Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last announced its earnings results on Thursday, January 5th. The pharmacy operator reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.01. The firm had revenue of $33.38 billion for the quarter, compared to the consensus estimate of $33.04 billion. Walgreens Boots Alliance had a positive return on equity of 13.57% and a negative net margin of 2.24%. The firm’s revenue for the quarter was down 1.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.68 EPS. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 4.5 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 10th. Stockholders of record on Thursday, February 16th were paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.83%. The ex-dividend date was Wednesday, February 15th. Walgreens Boots Alliance’s dividend payout ratio is presently -55.81%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on WBA. Loop Capital began coverage on Walgreens Boots Alliance in a research report on Wednesday, February 22nd. They issued a “buy” rating and a $45.00 target price for the company. StockNews.com began coverage on Walgreens Boots Alliance in a research report on Thursday. They issued a “hold” rating for the company. Cowen upgraded Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $43.00 to $54.00 in a research report on Tuesday, November 22nd. Cowen raised Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $43.00 to $54.00 in a report on Tuesday, November 22nd. Finally, Mizuho raised their price target on Walgreens Boots Alliance from $36.00 to $41.00 and gave the stock a “neutral” rating in a report on Wednesday, December 14th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $43.43.

Walgreens Boots Alliance Company Profile

(Get Rating)

Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.